Development and time-course of bleomycin-induced pulmonary fibrosis in NMRI mice

Daru

Volumn 15, Issue 1, 2007, Pages 1-6

  Jafarian Dehkordi, A ^a   Rabbani, M ^a   Mir Mohammad Sadeghi, H ^a   Afshar Moghaddam, N ^a   Alavi, S A ^b   Mahmoodi, F ^a   Safaeian, L ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Isfahan Science and Technology Town   (Iran)

Author keywords

Bleomycin; NMRI mice; Pulmonary fibrosis

Indexed keywords

BLEOMYCIN; KETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; FEMALE; HISTOPATHOLOGY; LUNG FIBROSIS; LUNG WEIGHT; MOUSE; NONHUMAN; SINGLE DRUG DOSE;

EID: 33947318987     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Suntres ZE, Shek PN. Protective effect of liposomal alpha tocopherol against bleomycin-induced lung injury. Biomed Environ Sci 1997; 10: 47-59.
2. Chandle DB. Possible mechanisms of bleomycin-induced fibrosis. Clin Chest Med 1990; 11: 21-30.
3. Grande NR, Peao MND, Sa CM, Aguas AP. Lung fibrosis induced by bleomycin: structural changes and overview of recent advances. Scanning Microsc 1998; 12(3): 487-494.
4. Usuki K, Fukuda Y. Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats. Pathol Int 1995; 45: 552-64.
5. Du Bois RM. The genetic predisposition to interstitial lung disease: functional relevance. Chest 2002; 121: 14S-20S.
6. Harrison JH, Lazo JS. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis. J Pharmacol Exp Ther 1988; 247(3): 1052-1058.
7. Lemay AM, Hanston CK. Bleomycin-induced pulmonary fibrosis susceptibility genes in AcB/BcA recombinant congenic mice. Physiol Genomics 2005; 23: 54-61.
8. Schrier DJ, Kunkel RG, Phan SH. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 1983; 127(1): 63-66.
9. Festing MFW. Genetic factors in toxicology, implication for toxicological screening. Crit Rev Toxicol 1987; 18: 1-26.
10. Barbarin V, Nihoul A, Misson P, Arras M, Delos M, Leclercq I, Lison D, Huaux F. The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis. Respir Res 2005; 7: 6-112.
11. Huaux F, Lardot C, Arras M, Delos M, Many MC, Coutelier JP, Buchet JP, Renauld JC, Lison D. Lung fibrosis induced by silica particles in NMRI mice is associated with an upreguation of the p40 subunit of interleukin-12 and Th-2 manifestations. Am J Respir Cell Mol Biol 1999; 20: 561-72.
12. Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Path 2002; 83(3): 111-119.
13. Keane MP, Belperio JA, Arenberg DA, Burdick MD, Xu ZJ, Xue YY, Strieter RM. IFN-γ-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 1999; 163: 5686-5692.
14. Ashcroft, T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41: 467-470.
15. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, Kolb M. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" Balb/c lungs. Am J Respir Cell Mol Biol 2004; 31: 510-516.
16. Salamone MF, Mavournin KH. Bone marrow micronucleus assay: a review of the mouse stocks used and their published mean spontaneous micronucleus frequencies. Environ Mol Mutagen 1994; 23: 239-73.
17. Haseman JK, Hole DG. Statistical design of toxicity assays: role of genetic structure of test animal population. J Toxicol Environ Health 1979; 5: 89-101.
18. Huaux F, Arras M, Vink A, Renauld JC, Lison D. Soluble tumor necrosis factor (TNF) receptor p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice. Am J Respir Cell Mol Biol 1999; 21: 137-45